Condition
Broader IBD news covering Crohn's disease, ulcerative colitis, research, treatments, monitoring, and patient care.
Page 27 of 88 · 4205 articles
Patients and surgeons weighing robotic versus laparoscopic IPAA for ulcerative colitis may care because the study suggests similar short-term complication rates between approaches in this cohort, which could inform...
Improved detection of divergent RNA viruses in gut metatranscriptomes could help researchers better characterize the viral component of the microbiome in IBD and explore possible viral contributions to disease biology or...
MRE is a key radiation-free imaging tool for children with Crohn’s disease; this review summarizes its clinical utility and how it fits with other pediatric-focused diagnostic approaches in Japan.
Genetic evidence that PBC may causally influence risk of IBD (and UC specifically) could help explain observed co-occurrence of these autoimmune diseases and point researchers toward shared pathways worth studying.
A new small molecule that blocks the NLRP3 inflammasome via ProRS could point to future drug strategies for ulcerative colitis — a pathway involved in intestinal inflammation that matters to people with IBD. This is...
The paper connects a host microRNA (miR-29a) to gut microbiota bile-acid metabolism and an anti-inflammatory bile acid (LCA). If similar mechanisms apply in people, it could point to new biological targets or biomarkers...
The study introduces a colon-targeted EGCG delivery system that reduced inflammation and improved microbial and metabolic markers in a mouse model of UC, suggesting a potential new therapeutic approach worth further...
Candidalysin is a toxin from Candida albicans that can damage epithelial barriers and trigger inflammation. If candidalysin contributes to intestinal inflammation or barrier dysfunction, it could help explain fungal...
The study connects a genetic regulator (PACSIN2) and Rac1 signaling to cellular responses to mercaptopurine, a drug used in IBD, offering a possible explanation for why some patients experience thiopurine-related gut...
Phages shape the gut microbial community and may behave differently in inflamed guts. Understanding phage evolution in IBD could eventually inform microbiome-targeted therapies or explain disease-associated microbial...
TGF-β1 is a central regulator implicated in inflammation control, development of fibrosis, and possible cancer progression in Crohn’s disease; advances in this area could inform future treatments or biomarker...
Cure8 could only read part of this source from tradingview.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Ulcerative colitis, Crohn's disease, and Inflammatory bowel disease.
Biologics are commonly recommended for moderate-to-severe Crohn's disease and can change disease course by healing inflammation, so understanding their benefits, risks, and cost/access issues helps patients make informed...
An orally dosed, gut-targeted PDE4 prodrug entering Phase 2 could offer a new locally acting anti-inflammatory option for people with UC or Crohn’s, potentially with fewer systemic side effects than older PDE4 drugs.
Stopping Crohn's medications can cause flares and serious complications, and restarting treatment may be slower or less effective. Adherence and financial or practical support can help prevent these harms.
The paper suggests that reduced folate transport can raise markers of inflammation-associated colon tumor initiation in mice, which is relevant because people with IBD are at higher risk for folate deficiency and colon...
Cure8 could only read part of this source from tradingview.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Inflammatory bowel disease and Research and clinical trials.
Treating fibrotic strictures would address an unmet need in Crohn’s disease — current approved drugs target inflammation, not established fibrosis. Positive Phase 2a signals could eventually lead to a new pharmacologic...
Based on the title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease and Medications. The original article is from Clinical and experimental gastroenterology.
Based on the title and source metadata, this appears to be an opinion or commentary related to Inflammatory bowel disease and Research and clinical trials. The original article is from Current opinion in pharmacology.
Baseline MRE features may help predict which Crohn's strictures will not improve with advanced medical therapy, informing monitoring and surgical planning. Better stratification could guide decisions about earlier...
Based on the title and source metadata, this appears to be a clinical study related to Ulcerative colitis, Inflammatory bowel disease, and Research and clinical trials. The original article is from Frontiers in...
Based on the title and source metadata, this appears to be a basic science related to Inflammatory bowel disease and Research and clinical trials. The original article is from Frontiers in immunology.
This study suggests a commonly eaten medicinal fruit extract has stable polyphenols through digestion and reduced inflammation in a zebrafish colitis model, which may be relevant to research into dietary approaches for...
Based on the title and source metadata, this appears to be a video related to Inflammatory bowel disease and Procedures and surgery. The original article is from hmpgloballearningnetwork.com.
Erythema nodosum can signal an underlying infection or systemic disease (including IBD) in children; recognizing common triggers helps guide evaluation and treatment.
Sustained fibroblast-to-myofibroblast transition (FMT) is linked to intestinal fibrosis and tumor-related stromal changes that can worsen outcomes in IBD. Understanding the cellular crosstalk that drives FMT could point...
Researchers link a bacterial metabolic pathway (pdu/pduB) in AIEC to intestinal inflammation and show that host vitamin B12 availability can reduce bacterial invasion and colitis in mice—suggesting a modifiable host...
Patients and clinicians often need real-world data on how methotrexate is actually used in IBD outside trials—this study shows it’s commonly paired with biologics, usually given subcutaneously, and has a median use of...
Cure8 could only read part of this source from jsonline.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Inflammatory bowel disease and Community and awareness.
Cure8 could only read part of this source from tradingview.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Inflammatory bowel disease and Research and clinical trials.
Bone marrow edema–like MRI signal in people with Crohn disease and prior steroid exposure can be an early warning sign of underlying bone fragility. Recognizing worsening load-related pain with such imaging may prompt...
Biopsy-based keratin patterns might help distinguish IBD, microscopic colitis, and IBS—conditions that can look similar clinically—so this could improve diagnostic accuracy if validated.
People with UC often use probiotics or microbiome-directed therapies alongside prescription drugs. Understanding probiotic–drug interactions could explain why individuals respond differently to IBD treatments and may...
If AIEC contribute to Crohn’s disease in some people, this study suggests bacterial metabolism linked to vitamin B12 can change how invasive and inflammatory those bacteria are. That points to the possibility of...
This trial tests a novel, tissue-derived cell therapy applied directly to intestinal ulcers — an approach that could lead to new local healing treatments for people with Crohn’s disease if proven safe and effective.
A new Phase 2 trial is testing afimkibart (RO7790121) for moderate-to-severe Crohn's disease; people with Crohn's disease who have failed prior treatments may be especially interested in emerging therapies.
Enteral nutrition (Modulen IBD) is being evaluated as a non-drug induction and maintenance strategy in children with Crohn’s disease; patients and caregivers may be interested because EEN can affect remission, nutrition,...
Surgery is still a core part of care for certain UC and Crohn's patients despite better medical therapies. Newer surgical techniques and coordinated medical–surgical approaches aim to reduce complications and recurrence...
This study links an epigenetic mechanism in macrophages (H2A.Z deposition) to microbial metabolites (butyrate) and to genetic variants associated with IBD, which may help explain persistent inflammation and variable...
Chronic antibiotic-refractory pouchitis is a common, impactful complication after ileal pouch-anal anastomosis that can worsen quality of life and increase the risk of pouch failure. Patients and clinicians need clearer...
Many people with UC try dietary supplements; this randomized trial tested grape seed extract and found a measurable reduction in an inflammation blood marker (hs‑CRP) but no clear improvement in most other measured...
This preclinical study connects an herbal medicine to changes in gut microbiota, inflammation, and intestinal barrier function in a mouse model of ulcerative colitis — findings that could inform future research on new...
People with ulcerative colitis may be interested because the study explores a plant extract that reduced inflammation markers in a common animal model of colitis, suggesting a possible new avenue for drug discovery or...
A decreasing need for IBD-related surgery after pediatric diagnosis could mean fewer major operations and related recovery for children and young adults. It may reflect the growing use of advanced medical therapies in...
A common heart drug, verapamil, reduced disease signs in a mouse model of colitis and altered inflammation and the gut microbiota — suggesting a possible avenue for future IBD research. These are preclinical results, so...
Noninvasive fecal calprotectin levels tracked with endoscopic disease activity in children with colonic Crohn's disease, suggesting FC could help reduce repeat endoscopies and better monitor treatment response.
The study maps layer-specific gene programs in fibrostenotic Crohn's disease and pinpoints the submucosa as a hotspot for fibromuscular remodeling that underlies strictures and bowel obstruction risk.
